Search
Returning search results with filters:
Remove filter for
Audience: Industry
Remove filter for
Issue: Unauthorized product
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 4 of 4 items.
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
The affected lots may contain an undeclared ingredient, bimatoprost, listed on the prescription drug list.
RecallHealth product recall | 2022-07-11
Product sold without market authorization. Affected lots are labelled with unauthorized claims.
RecallHealth product recall | 2022-06-30
All lots contain undeclared Isopropyl Cloprostenate that is listed on the prescription drug list.
RecallHealth product recall | 2022-04-19